Concepedia

Clara Delaunay

CD

7

Publications

1.1K

Citations

7

H-Index

2013

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Clara Delaunay is an author at Novartis (Switzerland) specializing in cell biology, tumor biology, and medicine.

ORCID

Top concepts

Publications per year

2013–2024

7

Publications

7

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

E. Robert McDonald, Antoine de Weck, Michael R. Schlabach et al. · Cell · 2017 · 687 citations · Full text

, , +13

Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

Emilie A. Chapeau, Laurent Sansregret, Giorgio Giacomo Galli et al. · Nature Cancer · 2024 · 104 citations · Full text

The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity

Chrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin et al. · PLoS ONE · 2013 · 93 citations · Full text

, , +18

Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ

Yannick Mesrouze, Marco Meyerhofer, Fedir Bokhovchuk et al. · Protein Science · 2017 · 65 citations · Full text

Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD

Yannick Mesrouze, Fedir Bokhovchuk, Marco Meyerhofer et al. · eLife · 2017 · 56 citations · Full text

Rows per page

1–5 of 7